Literature DB >> 19777083

NORMAL QUALITY OF LIFE AFTER THE COX MAZE PROCEDURE FOR ATRIAL FIBRILLATION.

Spencer J Melby1, Andreas Zierer, Jordon G Lubahn, Marci S Bailey, James L Cox, Richard B Schuessler, Ralph J Damiano.   

Abstract

BACKGROUND/
OBJECTIVE: Atrial fibrillation(AF) has been shown in numerous studies to significantly decrease patient quality of life. The Cox-Maze procedure has excellent long-term efficacy in curing AF. However, it is unknown whether this procedure improves long-term quality of life in these patients. The purpose of this study was to examine late quality of life in patients that underwent a lone Cox-Maze procedure.
METHODS: Between 1987 and 2003, 163 patients underwent a Cox-Maze procedure for lone AF at our institution. Of these, 68 patients agreed and completed the Medical Outcomes Study Short Form 36 Health Survey. Scores from the age-matched general US population were normalized to a mean of 50 and standard deviation of 10 to facilitate comparison. Collected data were compared to the norm-based score for each domain using a one-sample t-test. Four patients were removed from analysis because of AF recurrence.
RESULTS: There were 52 males(81%). Mean age was 52.6±9.5 years. Preoperatively, 37 patients(58%) had paroxysmal and 25 patients(39%) had persistent or permanent AF. The mean duration of AF before surgery was 9.8±8.2 years. There was no statistical difference in norm-based scores between the Cox-Maze procedure group and the age-matched general US population in any of the eight health domains at a mean follow-up of 8.7±3.7 years.
CONCLUSION: Our results suggest that the Cox-Maze procedure cures atrial fibrillation in the majority of patients, and that those patients that are cured obtain a normal quality of life as compared to the general population at late follow-up.

Entities:  

Year:  2008        PMID: 19777083      PMCID: PMC2748934          DOI: 10.1097/IMI.0b013e31819165d7

Source DB:  PubMed          Journal:  Innovations (Phila)        ISSN: 1556-9845


  35 in total

1.  The impairment of health-related quality of life in patients with intermittent atrial fibrillation: implications for the assessment of investigational therapy.

Authors:  P Dorian; W Jung; D Newman; M Paquette; K Wood; G M Ayers; J Camm; M Akhtar; B Luderitz
Journal:  J Am Coll Cardiol       Date:  2000-10       Impact factor: 24.094

2.  The Cox maze III procedure for atrial fibrillation: long-term efficacy in patients undergoing lone versus concomitant procedures.

Authors:  Sunil M Prasad; Hersh S Maniar; Cindy J Camillo; Richard B Schuessler; John P Boineau; Thoralf M Sundt; James L Cox; Ralph J Damiano
Journal:  J Thorac Cardiovasc Surg       Date:  2003-12       Impact factor: 5.209

3.  Impact of the maze procedure on the stroke rate in patients with atrial fibrillation.

Authors:  J L Cox; N Ad; T Palazzo
Journal:  J Thorac Cardiovasc Surg       Date:  1999-11       Impact factor: 5.209

4.  Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial.

Authors:  Oussama M Wazni; Nassir F Marrouche; David O Martin; Atul Verma; Mandeep Bhargava; Walid Saliba; Dianna Bash; Robert Schweikert; Johannes Brachmann; Jens Gunther; Klaus Gutleben; Ennio Pisano; Dominico Potenza; Raffaele Fanelli; Antonio Raviele; Sakis Themistoclakis; Antonio Rossillo; Aldo Bonso; Andrea Natale
Journal:  JAMA       Date:  2005-06-01       Impact factor: 56.272

5.  Quality of life in atrial fibrillation: the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.

Authors:  Louise S Jenkins; Michael Brodsky; Eleanor Schron; Mina Chung; Thomas Rocco; Ellis Lader; Martha Constantine; Robert Sheppard; Donald Holmes; Donna Mateski; Liz Floden; Marilyn Prasun; H Leon Greene; Lynn Shemanski
Journal:  Am Heart J       Date:  2005-01       Impact factor: 4.749

6.  Intraoperative microwave ablation for curative treatment of atrial fibrillation in open heart surgery--the MICRO-STAF and MICRO-PASS pilot trial. MICROwave Application in Surgical treatment of Atrial Fibrillation. MICROwave Application for the Treatment of Atrial Fibrillation in Bypass-Surgery.

Authors:  M Knaut; S G Spitzer; L Karolyi; H H Ebert; P Richter; S M Tugtekin; S Schüler
Journal:  Thorac Cardiovasc Surg       Date:  1999-08       Impact factor: 1.827

7.  Amiodarone versus sotalol for atrial fibrillation.

Authors:  Bramah N Singh; Steven N Singh; Domenic J Reda; X Charlene Tang; Becky Lopez; Crystal L Harris; Ross D Fletcher; Satish C Sharma; J Edwin Atwood; Alan K Jacobson; H Daniel Lewis; Dennis W Raisch; Michael D Ezekowitz
Journal:  N Engl J Med       Date:  2005-05-05       Impact factor: 91.245

8.  Combined atrial fibrillation and mitral valve surgery using microwave technology.

Authors:  Michael Knaut; Sems Malte Tugtekin; Stefan Spitzer; Vassilios Gulielmos
Journal:  Semin Thorac Cardiovasc Surg       Date:  2002-07

9.  Outpatient treatment of recent-onset atrial fibrillation with the "pill-in-the-pocket" approach.

Authors:  Paolo Alboni; Giovanni L Botto; Nicola Baldi; Mario Luzi; Vitantonio Russo; Lorella Gianfranchi; Paola Marchi; Massimo Calzolari; Alberto Solano; Raffaele Baroffio; Germano Gaggioli
Journal:  N Engl J Med       Date:  2004-12-02       Impact factor: 91.245

10.  Intraoperative microwave ablation in patients undergoing valvular surgery: midterm results.

Authors:  Andrea Venturini; Elvio Polesel; Valeria Cutaia; Angiolino Asta; Domenico Mangino; Roberto Moretti; Alberto Terrini; Claudio Zussa
Journal:  Heart Surg Forum       Date:  2003       Impact factor: 0.676

View more
  2 in total

1.  Cox-Maze IV results for patients with lone atrial fibrillation versus concomitant mitral disease.

Authors:  Lindsey L Saint; Marci S Bailey; Sunil Prasad; Tracey J Guthrie; Jennifer Bell; Marc R Moon; Jennifer S Lawton; Nabil A Munfakh; Richard B Schuessler; Ralph J Damiano; Hersh S Maniar
Journal:  Ann Thorac Surg       Date:  2012-02-02       Impact factor: 4.330

2.  The Cox maze IV procedure: predictors of late recurrence.

Authors:  Ralph J Damiano; Forrest H Schwartz; Marci S Bailey; Hersh S Maniar; Nabil A Munfakh; Marc R Moon; Richard B Schuessler
Journal:  J Thorac Cardiovasc Surg       Date:  2011-01       Impact factor: 5.209

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.